Tarek Moharram 2022 speaker

Group CEO

Elevate Capital

Biography

Dr. Tarek Moharram is the former CEO of Nile Scan & Labs, a leading regional diagnostics platform in the MEA region, succeeding his late father Dr. Hazem Moharram, who had previously established the Egyptian diagnostics company (full imaging, cardiology, oncology, and labs) over 25 years ago. He is a graduate with double majors, holding a MBBCH Medicine & Surgery from Cairo University as well as a Bachelor’s degree in political economy and management from the American University in Cairo (AUC). He successfully completed his Master’s in medicine from the University of Edinburgh and is currently pursuing his PhD in medicine at Imperial College London. This is in addition to executive education also from Imperial College London in the fields of finance management and private equity.

Dr. Tarek Moharram started his career at Nile Scan & Labs in 2008. During his tenure as CEO, Nile Scan & Labs’ revenue grew by a 7-year CAGR of 40%. Between 2016 and 2019, the company’s total capital investments amounted to USD60mn. By the time he led the diagnostics company’s exit, it had become a market share leader in oncology diagnostics and was valued at 5.7x its initial valuation before he assumed management.

Being both a medical practitioner as well as an investment professional, Dr. Tarek Moharram currently leads Elevate Capital in his capacity as CEO, managing new investments, M&As, and as well as guiding the holding company’s executive team. The firm is currently fundraising for the USD380mn Elevate Healthcare Fund –– the largest healthcare fund in North and Sub-Saharan Africa –– seeking to invest in hospitals, diagnostics, primary healthcare services, and insurance companies.